{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T08:56:38Z","timestamp":1770454598893,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Preventing breast cancer-related lymphedema (BCRL) by preserving upper lymphatic drainage is still controversial. Our study aimed to use the axillary reverse mapping (ARM) technique in patients who underwent axillary surgery to analyse the correlation between postoperative residual ARM nodes and the occurrence of lymphedema, select candidates at high risk of developing lymphedema, and analyse the oncologic safety of ARM nodes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients undergoing sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND) from October 2015 to February 2016 at the Peking University People\u2019s Hospital Breast Center were prospectively recruited for the study. ARM was performed in all patients before surgery. ARM nodes were separated from SLNB and ALND specimens. Data were collected on the identification of ARM nodes before surgery, number of residual ARM nodes after surgery, nodal status, crossover rate, and correlation between residual ARM nodes and the occurrence of lymphedema.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The analysis included 78 patients. Of the 53 patients who underwent SLNB, crossover between ARM nodes and breast sentinel lymph nodes (SLNs) was seen in 22 specimens. The incidence of ARM node metastasis was 1.89% (1\/53) and 25% (9\/36) in the SLNB and ALND groups, respectively. The number of positive axillary lymph nodes was associated with the involvement of ARM nodes (<jats:italic>P<\/jats:italic>= 0.036). The incidence of residual ARM nodes was significantly higher in the SLNB group than in the ALND group (67.6% vs. 37.9%,<jats:italic>P<\/jats:italic>= 0.016). The incidence of lymphedema was significantly higher in the ALND group than in the SLNB group (33.3% vs. 5.4%,<jats:italic>P<\/jats:italic>= 0.003).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>For SLNB, the ARM technique can help to resect SLNs more accurately. However, we do not recommend using the ARM technique to preserve ARM nodes in patients undergoing ALND due to oncologic safety issues. Nevertheless, we can predict patients undergoing axillary surgery who are more likely to have a high risk of lymphedema by assessing residual ARM nodes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>This study was registered on<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>in February 2016.<\/jats:p><jats:p>The clinical trial registration number is<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02691624?term=breast+cancer&amp;cond=Lymphedema&amp;cntry=CN&amp;city=Beijing&amp;draw=2&amp;rank=2\">NCT02691624<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12957-020-01886-9","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T20:02:14Z","timestamp":1591041734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema"],"prefix":"10.1186","volume":"18","author":[{"given":"Siyao","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houpu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8651-4795","authenticated-orcid":false,"given":"Shu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,1]]},"reference":[{"key":"1886_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/bjs.10041","volume":"103","author":"M Ahmed","year":"2016","unstructured":"Ahmed M, Rubio IT, Kovacs T, et al. Systematic review of axillary reverse mapping in breast cancer. Br J Surg. 2016;103:170\u20138.","journal-title":"Br J Surg"},{"key":"1886_CR2","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","volume":"25","author":"A Lucci","year":"2007","unstructured":"Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007;25:3657\u201363.","journal-title":"J Clin Oncol"},{"key":"1886_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12282-018-0886-0","volume":"26","author":"X Shao","year":"2019","unstructured":"Shao X, Sun B, Shen Y. Axillary reverse mapping (ARM): where to go. Breast Cancer. 2019;26:1\u201310.","journal-title":"Breast Cancer"},{"key":"1886_CR4","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1245\/s10434-007-9412-x","volume":"14","author":"M Thompson","year":"2007","unstructured":"Thompson M, Korourian S, Henry-Tillman R, et al. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Oncol. 2007;14:1890\u20135.","journal-title":"Ann Surg Oncol"},{"key":"1886_CR5","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1245\/s10434-007-9450-4","volume":"14","author":"C Nos","year":"2007","unstructured":"Nos C, Lesieur B, Clough KB, Lecuru F. Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection. Ann Surg Oncol. 2007;14:2490\u20136.","journal-title":"Ann Surg Oncol"},{"key":"1886_CR6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/jso.20905","volume":"97","author":"VS Klimberg","year":"2008","unstructured":"Klimberg VS. A new concept toward the prevention of lymphedema: axillary reverse mapping. J Surg Oncol. 2008;97:563\u20134.","journal-title":"J Surg Oncol"},{"key":"1886_CR7","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1245\/s10434-009-0554-x","volume":"16","author":"F Casabona","year":"2009","unstructured":"Casabona F, Bogliolo S, Valenzano Menada M, et al. Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer patients. Ann Surg Oncol. 2009;16:2459\u201363.","journal-title":"Ann Surg Oncol"},{"key":"1886_CR8","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.ejso.2013.09.022","volume":"39","author":"M Gennaro","year":"2013","unstructured":"Gennaro M, Maccauro M, Sigari C, et al. Selective axillary dissection after axillary reverse mapping to prevent breast-cancer-related lymphoedema. Eur J Surg Oncol. 2013;39:1341\u20135.","journal-title":"Eur J Surg Oncol"},{"key":"1886_CR9","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.ejso.2013.05.009","volume":"39","author":"C Tausch","year":"2013","unstructured":"Tausch C, Baege A, Dietrich D, et al. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients? Eur J Surg Oncol. 2013;39:880\u20136.","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"1886_CR10","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1245\/s10434-013-3113-4","volume":"20","author":"C Connor","year":"2013","unstructured":"Connor C, Mcginness M, Mammen J, et al. Axillary reverse mapping: a prospective study in women with clinically node negative and node positive breast cancer. Ann Surg Oncol. 2013;20(10):3303\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"1886_CR11","volume":"11","author":"C Han","year":"2016","unstructured":"Han C, Yang B, Zuo WS, et al. The feasibility and oncological safety of axillary reverse mapping in patients with breast cancer: a systematic review and meta-analysis of prospective studies. PLoS One. 2016;11(2):e0150285.1.","journal-title":"PLoS One"},{"issue":"5","key":"1886_CR12","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jamcollsurg.2007.12.022","volume":"206","author":"C Boneti","year":"2008","unstructured":"Boneti C, Korourian S, Bland K, et al. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. J Am Coll Surg. 2008;206(5):1038\u201342 discussion 1042-1044.","journal-title":"J Am Coll Surg"},{"issue":"7","key":"1886_CR13","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1245\/s10434-014-3626-5","volume":"21","author":"E Schunemann Jr","year":"2014","unstructured":"Schunemann E Jr, Doria MT, Silvestre JB, et al. Prospective study evaluating oncological safety of axillary reverse mapping. Ann Surg Oncol. 2014;21(7):2197\u2013202.","journal-title":"Ann Surg Oncol"},{"key":"1886_CR14","doi-asserted-by":"publisher","first-page":"15241","DOI":"10.1038\/srep15241","volume":"5","author":"M Liu","year":"2015","unstructured":"Liu M, Wang S, Cui S, et al. The feasibility of the ACOSOG Z0011 criteria to Chinese breast cancer patients: a multicenter study. Sci Rep. 2015;5:15241.","journal-title":"Sci Rep"},{"key":"1886_CR15","doi-asserted-by":"publisher","first-page":"452","DOI":"10.20892\/j.issn.2095-3941.2018.0270","volume":"15","author":"L Yuan","year":"2018","unstructured":"Yuan L, Qi X, Zhang Y, et al. Comparison of sentinel lymph node detection performances using blue dye in conjunction with indocyanine green or radioisotope in breast cancer patients: a prospective single-center randomized study. Cancer Biol Med. 2018;15:452\u201360.","journal-title":"Cancer Biol Med"},{"key":"1886_CR16","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1245\/s10434-008-0030-z","volume":"15","author":"C Nos","year":"2008","unstructured":"Nos C, Kaufmann G, Clough KB, et al. Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection. Ann Surg Oncol. 2008;15:2550\u20135.","journal-title":"Ann Surg Oncol"},{"key":"1886_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/MNM.0b013e328315a6c6","volume":"30","author":"TB Britton","year":"2009","unstructured":"Britton TB, Solanki CK, Pinder SE, et al. Lymphatic drainage pathways of the breast and the upper limb. Nucl Med Commun. 2009;30:427\u201330.","journal-title":"Nucl Med Commun"},{"issue":"12","key":"1886_CR18","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.ejso.2011.09.001","volume":"37","author":"TR Lopez Penha","year":"2011","unstructured":"Lopez Penha TR, Slangen JJG, Heuts EM, et al. Prevalence of lymphoedema more than five years after breast cancer treatment. Eur J Surg Oncol. 2011;37(12):1059\u201363.","journal-title":"Eur J Surg Oncol"},{"key":"1886_CR19","doi-asserted-by":"publisher","first-page":"e392","DOI":"10.1016\/S1470-2045(16)30204-2","volume":"17","author":"MS Asdourian","year":"2016","unstructured":"Asdourian MS, Skolny MN, Brunelle C, et al. Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis. The Lancet Oncology. 2016;17:e392\u2013405.","journal-title":"The Lancet Oncology"},{"key":"1886_CR20","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/jso.23720","volume":"110","author":"U Kuusk","year":"2014","unstructured":"Kuusk U, Seyednejad N, McKevitt EC, et al. Axillary reverse mapping in breast cancer: a Canadian experience. J Surg Oncol. 2014;110:791\u20135.","journal-title":"J Surg Oncol"},{"key":"1886_CR21","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.amjsurg.2009.06.008","volume":"198","author":"C Boneti","year":"2009","unstructured":"Boneti C, Korourian S, Diaz Z, et al. Scientific Impact Award: Axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy. Am J Surg. 2009;198:482\u20137.","journal-title":"Am J Surg"},{"key":"1886_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/jso.22094","volume":"105","author":"M Noguchi","year":"2012","unstructured":"Noguchi M, Noguchi M, Nakano Y, et al. Axillary reverse mapping using a fluorescence imaging system in breast cancer. J Surg Oncol. 2012;105:229\u201334.","journal-title":"J Surg Oncol"},{"key":"1886_CR23","doi-asserted-by":"crossref","unstructured":"Guo J, Yang H, Wang S, et al. Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study. World Journal of Surgical Oncology. 2017;15.","DOI":"10.1186\/s12957-017-1264-7"},{"key":"1886_CR24","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","volume":"15","author":"B Fisher","year":"1997","unstructured":"Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 1997;15:2483\u201393.","journal-title":"J Clin Oncol"},{"key":"1886_CR25","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1200\/JCO.2009.22.1846","volume":"27","author":"R Ponzone","year":"2009","unstructured":"Ponzone R, Cont NT, Maggiorotto F, et al. Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer. J Clin Oncol. 2009;27:5547\u201351.","journal-title":"J Clin Oncol"},{"key":"1886_CR26","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1002\/cncr.25096","volume":"116","author":"I Bedrosian","year":"2010","unstructured":"Bedrosian I, Babiera GV, Mittendorf EA, et al. A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer. 2010;116:2543\u20138.","journal-title":"Cancer"},{"key":"1886_CR27","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/jso.24231","volume":"113","author":"NK Ngui","year":"2016","unstructured":"Ngui NK, French J, Kilby CJ, et al. Axillary reverse mapping in patients with breast cancer: is it oncologically safe? Journal of Surgical Oncology. 2016;113:726\u201331.","journal-title":"Journal of Surgical Oncology"},{"key":"1886_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejso.2014.09.012","volume":"41","author":"MA Beek","year":"2015","unstructured":"Beek MA, Gobardhan PD, Klompenhouwer EG, et al. Axillary reverse mapping (ARM) in clinically node positive breast cancer patients. Eur J Surg Oncol. 2015;41:59\u201363.","journal-title":"Eur J Surg Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-020-01886-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-020-01886-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-020-01886-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T19:46:19Z","timestamp":1722973579000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-020-01886-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1886"],"URL":"https:\/\/doi.org\/10.1186\/s12957-020-01886-9","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,1]]},"assertion":[{"value":"11 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Committee of the Peking University People\u2019s Hospital (2020PHB020-01) approved this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}